Clinical application of exhaled nitric oxide measurements in a Korean population

Woo Jung Song; Ji Won Kwon; Eun Jin Kim; Sang Min Lee; Sae Hoon Kim; So Yeon Lee; Sang Heon Kim; Heung Woo Park; Yoon Seok Chang; Woo Kyung Kim; Jung Yeon Shim; Ju Hee Seo; Byoung Ju Kim; Hyo Bin Kim; Dae Jin Song; Gwang Cheon Jang; An Soo Jang; Jung Won Park; Ho Joo Yoon; Joo Shil Lee; Sang Heon Cho; Soo Jong Hong

doi:10.4168/aair.2015.7.1.3

Clinical application of exhaled nitric oxide measurements in a Korean population

Woo Jung Song, Ji Won Kwon, Eun Jin Kim, Sang Min Lee, Sae Hoon Kim, So Yeon Lee, Sang Heon Kim, Heung Woo Park, Yoon Seok Chang, Woo Kyung Kim, Jung Yeon Shim, Ju Hee Seo, Byoung Ju Kim, Hyo Bin Kim, Dae Jin Song, Gwang Cheon Jang, An Soo Jang, Jung Won Park, Ho Joo Yoon, Joo Shil LeeSang Heon Cho, Soo Jong Hong

Research output: Contribution to journal › Review article › peer-review

21 Citations (Scopus)

Abstract

Nitric oxide (NO) is a biologic mediator of various physiologic functions. Recent evidence suggests the clinical utility of fractional exhaled NO (FeNO) as a biomarker for assessing asthma and other respiratory diseases. FeNO methodologies have been recently standardized by international research groups and subsequently validated in several Korean population studies. Normal ranges for FeNO have been reported for various ethnic groups, and the clinical utility has been widely evaluated in asthma and various respiratory diseases. Based on current evidence including most of Korean population data, this position paper aims to introduce the methodological considerations, and provide the guidance for the proper clinical application of FeNO measurements in Korean populations.

Original language	English
Pages (from-to)	3-13
Number of pages	11
Journal	Allergy, Asthma and Immunology Research
Volume	7
Issue number	1
DOIs	https://doi.org/10.4168/aair.2015.7.1.3
Publication status	Published - 2014
Externally published	Yes

Keywords

Asthma
Exhaled nitric oxide
Guideline
Position paper
Reference value

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pulmonary and Respiratory Medicine

Access to Document

10.4168/aair.2015.7.1.3

Cite this

Song, W. J., Kwon, J. W., Kim, E. J., Lee, S. M., Kim, S. H., Lee, S. Y., Kim, S. H., Park, H. W., Chang, Y. S., Kim, W. K., Shim, J. Y., Seo, J. H., Kim, B. J., Kim, H. B., Song, D. J., Jang, G. C., Jang, A. S., Park, J. W., Yoon, H. J., ... Hong, S. J. (2014). Clinical application of exhaled nitric oxide measurements in a Korean population. Allergy, Asthma and Immunology Research, 7(1), 3-13. https://doi.org/10.4168/aair.2015.7.1.3

Song, WJ, Kwon, JW, Kim, EJ, Lee, SM, Kim, SH, Lee, SY, Kim, SH, Park, HW, Chang, YS, Kim, WK, Shim, JY, Seo, JH, Kim, BJ, Kim, HB, Song, DJ, Jang, GC, Jang, AS, Park, JW, Yoon, HJ, Lee, JS, Cho, SH & Hong, SJ 2014, 'Clinical application of exhaled nitric oxide measurements in a Korean population', Allergy, Asthma and Immunology Research, vol. 7, no. 1, pp. 3-13. https://doi.org/10.4168/aair.2015.7.1.3

@article{0fc656ed4fe94e529d668d745c9c00c2,

title = "Clinical application of exhaled nitric oxide measurements in a Korean population",

abstract = "Nitric oxide (NO) is a biologic mediator of various physiologic functions. Recent evidence suggests the clinical utility of fractional exhaled NO (FeNO) as a biomarker for assessing asthma and other respiratory diseases. FeNO methodologies have been recently standardized by international research groups and subsequently validated in several Korean population studies. Normal ranges for FeNO have been reported for various ethnic groups, and the clinical utility has been widely evaluated in asthma and various respiratory diseases. Based on current evidence including most of Korean population data, this position paper aims to introduce the methodological considerations, and provide the guidance for the proper clinical application of FeNO measurements in Korean populations.",

keywords = "Asthma, Exhaled nitric oxide, Guideline, Position paper, Reference value",

author = "Song, {Woo Jung} and Kwon, {Ji Won} and Kim, {Eun Jin} and Lee, {Sang Min} and Kim, {Sae Hoon} and Lee, {So Yeon} and Kim, {Sang Heon} and Park, {Heung Woo} and Chang, {Yoon Seok} and Kim, {Woo Kyung} and Shim, {Jung Yeon} and Seo, {Ju Hee} and Kim, {Byoung Ju} and Kim, {Hyo Bin} and Song, {Dae Jin} and Jang, {Gwang Cheon} and Jang, {An Soo} and Park, {Jung Won} and Yoon, {Ho Joo} and Lee, {Joo Shil} and Cho, {Sang Heon} and Hong, {Soo Jong}",

note = "Publisher Copyright: {\textcopyright} Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology.",

year = "2014",

doi = "10.4168/aair.2015.7.1.3",

language = "English",

volume = "7",

pages = "3--13",

journal = "Allergy, Asthma and Immunology Research",

issn = "2092-7355",

publisher = "Korean Academy of Asthma, Allergy and Clinical Immunology",

number = "1",

}

TY - JOUR

T1 - Clinical application of exhaled nitric oxide measurements in a Korean population

AU - Song, Woo Jung

AU - Kwon, Ji Won

AU - Kim, Eun Jin

AU - Lee, Sang Min

AU - Kim, Sae Hoon

AU - Lee, So Yeon

AU - Kim, Sang Heon

AU - Park, Heung Woo

AU - Chang, Yoon Seok

AU - Kim, Woo Kyung

AU - Shim, Jung Yeon

AU - Seo, Ju Hee

AU - Kim, Byoung Ju

AU - Kim, Hyo Bin

AU - Song, Dae Jin

AU - Jang, Gwang Cheon

AU - Jang, An Soo

AU - Park, Jung Won

AU - Yoon, Ho Joo

AU - Lee, Joo Shil

AU - Cho, Sang Heon

AU - Hong, Soo Jong

PY - 2014

Y1 - 2014

N2 - Nitric oxide (NO) is a biologic mediator of various physiologic functions. Recent evidence suggests the clinical utility of fractional exhaled NO (FeNO) as a biomarker for assessing asthma and other respiratory diseases. FeNO methodologies have been recently standardized by international research groups and subsequently validated in several Korean population studies. Normal ranges for FeNO have been reported for various ethnic groups, and the clinical utility has been widely evaluated in asthma and various respiratory diseases. Based on current evidence including most of Korean population data, this position paper aims to introduce the methodological considerations, and provide the guidance for the proper clinical application of FeNO measurements in Korean populations.

AB - Nitric oxide (NO) is a biologic mediator of various physiologic functions. Recent evidence suggests the clinical utility of fractional exhaled NO (FeNO) as a biomarker for assessing asthma and other respiratory diseases. FeNO methodologies have been recently standardized by international research groups and subsequently validated in several Korean population studies. Normal ranges for FeNO have been reported for various ethnic groups, and the clinical utility has been widely evaluated in asthma and various respiratory diseases. Based on current evidence including most of Korean population data, this position paper aims to introduce the methodological considerations, and provide the guidance for the proper clinical application of FeNO measurements in Korean populations.

KW - Asthma

KW - Exhaled nitric oxide

KW - Guideline

KW - Position paper

KW - Reference value

UR - http://www.scopus.com/inward/record.url?scp=84919348598&partnerID=8YFLogxK

U2 - 10.4168/aair.2015.7.1.3

DO - 10.4168/aair.2015.7.1.3

M3 - Review article

AN - SCOPUS:84919348598

SN - 2092-7355

VL - 7

SP - 3

EP - 13

JO - Allergy, Asthma and Immunology Research

JF - Allergy, Asthma and Immunology Research

IS - 1

ER -

Clinical application of exhaled nitric oxide measurements in a Korean population

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this